International sales fuel OEC results

Article

Strong international acceptance of its Series 9600 mobile C-armhas helped OEC Medical Systems record sharply higher revenuesand profits for its second quarter (end-June). The Salt Lake Citycompany had second-quarter revenues of $26.1 million, up 34%

Strong international acceptance of its Series 9600 mobile C-armhas helped OEC Medical Systems record sharply higher revenuesand profits for its second quarter (end-June). The Salt Lake Citycompany had second-quarter revenues of $26.1 million, up 34% overthe $19.4 million in product sales in the same period last year.Net income was $2.8 million, compared to $300,000 in the secondquarter of 1994.

OEC was bedeviled by delays in shipping Series 9600 last yearthat were reflected in the company's 1994 results, but those bugshave been worked out, according to chairman, president and CEORuediger Naumann-Etienne. OEC's numbers this year were aided bystrong international demand for the product. International salesfor the first six months of 1995 have already exceeded the totalrecorded last year, he said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.